Clinical effects and blood concentration of vancomycin:32 cases report
-
摘要: 目的 评价我院32例患者万古霉素血药浓度监测结果与临床疗效分析,为临床合理用药提供参考。 方法 对我院2011年12月~2012年4月应用万古霉素并监测血药浓度的32例住院患者的临床资料(基础疾病、细菌学培养结果、用药情况、万古霉素血药谷浓度、疗效、肾功能情况等)进行统计、分析。 结果 细菌检出率53%,用药指征细菌学符合率31%。应用万古霉素的总有效率为69%,万古霉素血药浓度所测得谷值在10~20 mg/L范围内者占25%,治疗后肾功能异常发生率为13%。 结论 32例应用万古霉素患者初次测得其血药浓度谷值在有效范围内的比例偏低,对老年患者需重视其血药浓度监测,并结合临床实际实现个体化给药。Abstract: Objective To evaluate clinical utilization and blood concentration monitoring of vancomycin in our hospital and offer reference to reasonable clinical use of drugs. Methods The clinical information (primary diseases, bacteriological culture, blood concentration of vancomycin, clinical efficacy, renal function) of 32 inpatients who had been treated with vancomycin and their blood concentrations from Dec. 2011 to Apr. 2012 were analyzed statistically. Results The bacteria detection rate was 53%. The drug indications bacteriology coincidence rate was 31%. The total response rate of vancomycin was 68.75%. The valley values of 25% cases were between 10 mg/L and 20 mg/L. The incidence of renal dysfunction after treatment was 12.5%. Conclusion The valley value of blood concentration of the 32 cases using vancomycin that first measured were less in effective range which should be paid attention to the blood concentration monitoring of agedness patients to achieve an ideal individual administration according to clinical practice.
-
Key words:
- vancomycin /
- blood concentration monitoring /
- clinical use of drugs
-
[1] 黄仲义,肖永红,张菁.万古霉素临床应用中国专家共识(2011版)[J].中国新药与临床杂志,2011,30(8):561. [2] 刘振声,金大鹏,陈增辉.医院感染管理学[M].北京:军事医学科学出版社,2008:328. [3] 王爱霞,范洪伟,吕玮,等.桑福德抗微生物治疗指南(新译第41版)2011-2012[M].北京:中国协和医科大学出版社,2011:39. [4] Liu C,Bayer A,Cosgrove SE,et al.Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children[J].Clin infect Dis,2011,52(3):e18. [5] Rybak M,Lomaestro B,Rotschafer JC,et al.Therapeutic monitoring of vancomycin in adult patients:a consensus review of the American Society of Health-System Pharmacists,the Infectious Diseases Society of America,and the Society of Infectious Diseases Pharmacists[J].Am J Health Syst pharm,2009,66:82. [6] Rybak MJ.The pharmacokinetic and pharmacodynamic properties of vancomycin[J].Clin Infect Dis,2006,42(Suppl.1):S35 -
点击查看大图
计量
- 文章访问数: 2836
- HTML全文浏览量: 320
- PDF下载量: 93
- 被引次数: 0
下载:
